Anticoagulant in Acute Ischemic Stroke with Atrial Fibrillation: A Narrative Review

Authors

  • S K Jakaria Been Sayeed Medicine & Rheumatology Specialist, National Institute of Neurosciences and Hospital, Dhaka
  • Md Moniruzzaman Junior Consultant, Medicine, National Institute of Neurosciences and Hospital, Dhaka.
  • Md Mujibur Rahman Professor of Medicine, Popular Medical College Hospital, Dhaka.

DOI:

https://doi.org/10.3329/jom.v25i2.74657

Keywords:

Anticoagulant, Atrial fibrillation, Ischemic stroke

Abstract

Embolic stroke due to atrial fibrillation is often underdiagnosed and has high morbidity and mortality among ischemic stroke. So it is of paramount importance to start anticoagulants as early as possible to prevent further ischemic stroke. However, early initiation of anticoagulants has created much debate, major & minor bleeding related to it are a major concern, and resumption of anticoagulants after intracranial hemorrhage is still a gray zone. Here, we described a narrative review to shed some light on the major concerns such as the optimal time to start an anticoagulant, the best agent to administer, the resumption of anticoagulant after a hemorrhagic stroke, and anticoagulant therapy in chronic rheumatic heart disease (CRHD) based on the recently published article.

J MEDICINE 2024; 25: 155-158

Downloads

Download data is not yet available.
Abstract
145
PDF
181

Downloads

Published

2024-07-16

How to Cite

Sayeed, S. K. J. B., Moniruzzaman, M., & Rahman, M. M. (2024). Anticoagulant in Acute Ischemic Stroke with Atrial Fibrillation: A Narrative Review. Journal of Medicine, 25(2), 155–158. https://doi.org/10.3329/jom.v25i2.74657

Issue

Vol. 25 No. 2 (2024)

Section

Review Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).